Page last updated: 2024-08-17

triamcinolone acetonide and Blindness

triamcinolone acetonide has been researched along with Blindness in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19902 (20.00)18.7374
1990's0 (0.00)18.2507
2000's3 (30.00)29.6817
2010's4 (40.00)24.3611
2020's1 (10.00)2.80

Authors

AuthorsStudies
Desai, A; Sen, S; Singh, P1
Adams, E; Arroyo, S; Duran, J; Grant-Greene, Y; Harris, JR; Kim, M; Lee, EH; Lockhart, SR; Mascola, L; Mikosz, CA; Park, BJ; Robinson, BF; Smith, RM; Sowadsky, R; Straif-Bourgeois, S; Török, TJ; Tyson, C; Vasquez, Y1
Karnezis, TT; Kjos, KB; Lebovits, MJ; Moss, WJ1
Allen, LH; Li, B; Sheidow, TG1
Antoszyk, AN; Blodi, BA; Ip, MS; Oden, NL; Scott, IU; VanVeldhuisen, PC1
Arcidiacono, B; Becerra, EM; Danzi, P; Gandolfo, F; Morescalchi, F; Nascimbeni, G; Semeraro, F1
Juarez, CP; Luna, JD; Rodriguez, ML1
POLANO, MK1
Gillies, MC; Larsson, J1
Orentreich, N; Selmanowitz, VJ1

Reviews

2 review(s) available for triamcinolone acetonide and Blindness

ArticleYear
Intranasal steroid injections and blindness: our personal experience and a review of the past 60 years.
    The Laryngoscope, 2015, Volume: 125, Issue:4

    Topics: Administration, Intranasal; Adult; Aged; Aged, 80 and over; Blindness; Chronic Disease; Cohort Studies; Female; Follow-Up Studies; Glucocorticoids; Humans; Incidence; Injections, Intralesional; Male; Middle Aged; Patient Safety; Retrospective Studies; Rhinitis; Risk Assessment; Sinusitis; Time Factors; Treatment Outcome; Triamcinolone Acetonide; Young Adult

2015
Clinical evidence of intravitreal triamcinolone acetonide in the management of age-related macular degeneration.
    Current drug targets, 2011, Volume: 12, Issue:2

    Topics: Angiogenesis Inhibitors; Animals; Anti-Inflammatory Agents; Blindness; Choroidal Neovascularization; Combined Modality Therapy; Delayed-Action Preparations; Humans; Hyperthermia, Induced; Intravitreal Injections; Macular Degeneration; Photochemotherapy; Photosensitizing Agents; Porphyrins; Triamcinolone Acetonide; Vascular Endothelial Growth Factors; Verteporfin; Wet Macular Degeneration

2011

Trials

2 trial(s) available for triamcinolone acetonide and Blindness

ArticleYear
SCORE Study Report 7: incidence of intravitreal silicone oil droplets associated with staked-on vs luer cone syringe design.
    American journal of ophthalmology, 2009, Volume: 148, Issue:5

    Topics: Blindness; Equipment Design; Eye Foreign Bodies; Glucocorticoids; Humans; Incidence; Injections; Macular Edema; Prospective Studies; Retinal Vein Occlusion; Silicone Oils; Syringes; Triamcinolone Acetonide; Vitreous Body

2009
Intravitreal triamcinolone acetonide injection in blind painful eyes. Intraocular steroids as a treatment for blind painful red eyes.
    European journal of ophthalmology, 2003, Volume: 13, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Blindness; Child; Female; Glucocorticoids; Humans; Injections; Male; Middle Aged; Pain; Palliative Care; Placebo Effect; Safety; Treatment Outcome; Triamcinolone Acetonide; Visually Impaired Persons; Vitreous Body

2003

Other Studies

6 other study(ies) available for triamcinolone acetonide and Blindness

ArticleYear
Periocular Necrobiotic Xanthogranuloma-A Case of Unseen Eyes.
    JAMA ophthalmology, 2020, 08-01, Volume: 138, Issue:8

    Topics: Administration, Oral; Adult; Blindness; Cyclophosphamide; Drug Therapy, Combination; Eyelid Diseases; Female; Giant Cells; Glucocorticoids; Histiocytes; Humans; Immunosuppressive Agents; Injections, Intralesional; Male; Necrobiotic Xanthogranuloma; Ophthalmologic Surgical Procedures; Skin Diseases; Triamcinolone Acetonide

2020
Fungal endophthalmitis associated with compounded products.
    Emerging infectious diseases, 2014, Volume: 20, Issue:2

    Topics: Aged; Aged, 80 and over; Blindness; Drug Recalls; Endophthalmitis; Eye Infections, Fungal; Female; Fusarium; Humans; Male; Middle Aged; Ophthalmic Solutions; Retina; Rosaniline Dyes; Saccharomycetales; Triamcinolone Acetonide; United States; Vitreous Body

2014
Vision loss and vascular compromise with facial and periocular injections.
    Canadian journal of ophthalmology. Journal canadien d'ophtalmologie, 2015, Volume: 50, Issue:4

    Topics: Aged; Arterial Occlusive Diseases; Blindness; Cataract Extraction; Eye Pain; Female; Fluorescein Angiography; Glucocorticoids; Humans; Injections, Intraocular; Lacrimal Apparatus; Macular Edema; Magnetic Resonance Imaging; Oculomotor Muscles; Ophthalmic Artery; Tenon Capsule; Tomography, Optical Coherence; Triamcinolone Acetonide

2015
Triamcinolone acetonide cream in a double-blind test.
    Archives of dermatology, 1961, Volume: 83

    Topics: Blindness; Double-Blind Method; Eczema; Humans; Triamcinolone; Triamcinolone Acetonide

1961
Severe loss of vision after removal of cataract caused by intravitreal triamcinolone in combination with photodynamic therapy for exudative age-related macular degeneration.
    Clinical & experimental ophthalmology, 2005, Volume: 33, Issue:5

    Topics: Aged; Blindness; Cataract; Cataract Extraction; Drug Therapy, Combination; Female; Fluorescein Angiography; Glucocorticoids; Humans; Injections; Macular Degeneration; Photochemotherapy; Photosensitizing Agents; Triamcinolone Acetonide; Visual Acuity; Vitreous Body

2005
Cutaneous corticosteroid injection and amaurosis. Analysis for cause and prevention.
    Archives of dermatology, 1974, Volume: 110, Issue:5

    Topics: Alopecia Areata; Blindness; Blood Pressure; Embolism; Eye; Female; Humans; Hydrocortisone; Injections, Intradermal; Male; Methylprednisolone; Ophthalmic Artery; Particle Size; Scalp; Suspensions; Triamcinolone Acetonide

1974